Asset purchase and licensing agreement for hemophilia-related assets plus anti- TFPI aptamer technologyAsset Purchase and Licensing Agreement • November 7th, 2020Contract TypeAsset Purchase and Licensing AgreementFiledNovember 7th, 2020